# Marsili Syndrome as a Gateway to Novel Analgesic Targets

> **NCT07755930** · NA · NOT_YET_RECRUITING · sponsor: **Aalborg University** · enrollment: 4 (estimated)

## Conditions studied

- Marsili Syndrome

## Interventions

- **OTHER:** Histamine
- **OTHER:** Cowhage (Mucuna Pruriens)
- **DRUG:** Capsaicin 8% Patch
- **OTHER:** Knee Injections of hypertonic saline
- **OTHER:** Cold Pressure Test
- **OTHER:** Computerized Conditioned Pain Modulation (CPM)

## Key facts

- **NCT ID:** NCT07755930
- **Lead sponsor:** Aalborg University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 4 (ESTIMATED)
- **Last updated:** 2026-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07755930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07755930, "Marsili Syndrome as a Gateway to Novel Analgesic Targets". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07755930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
